Lubazodone

Lubazodone (YM-992, YM-35,995) is an antidepressant which was being developed as a treatment for depression but was discontinued. It acts as a serotonin reuptake inhibitor and 5-HT2A receptor antagonist. Lubazodone made it to phase II clinical trials but was discontinued in 2001.